See more : Vascon Engineers Limited (VASCONEQ.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Can B Corp. (CANB) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Can B Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Hana Microelectronics Public Company Limited (HANA.BK) Income Statement Analysis – Financial Results
- Horizon Technology Finance Corporation (HRZN) Income Statement Analysis – Financial Results
- Waystar Holding Corp. (WAY) Income Statement Analysis – Financial Results
- AbbVie Inc. (0QCV.L) Income Statement Analysis – Financial Results
- Quantum FinTech Acquisition Corporation (QFTA-UN) Income Statement Analysis – Financial Results
Can B Corp. (CANB)
About Can B Corp.
Can B Corp. develops, manufactures, and sells cannabidiol (CBD) based products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and life style products through its Website and vending machines, and other medical professionals. It offers its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.16M | 6.69M | 4.60M | 1.71M | 2.31M | 668.60K | 122.75K | 95.15K | 103.04K | 32.57K | 16.36K | 24.10K | 2.07K | 22.90K |
| Cost of Revenue | 1.80M | 4.07M | 1.61M | 278.06K | 598.58K | 405.53K | 44.47K | 72.30K | 0.00 | 404.00 | 2.24K | 404.00 | 15.41K | 14.34K |
| Gross Profit | 358.70K | 2.61M | 2.99M | 1.43M | 1.71M | 263.07K | 78.28K | 22.84K | 103.04K | 32.17K | 14.12K | 23.69K | -13.34K | 8.56K |
| Gross Profit Ratio | 16.64% | 39.11% | 64.99% | 83.74% | 74.04% | 39.35% | 63.77% | 24.01% | 100.00% | 98.76% | 86.31% | 98.32% | -645.28% | 37.36% |
| Research & Development | 0.00 | 0.00 | 0.00 | 165.00K | 150.00K | 75.00K | 37.00K | 0.00 | 276.99K | 1.03K | 140.91K | 0.00 | 0.00 | 9.05K |
| General & Administrative | 4.75M | 13.54M | 9.64M | 4.61M | 5.80M | 3.59M | 599.75K | 424.81K | 1.61M | 58.76K | 328.33K | 1.67M | 1.13M | 1.08M |
| Selling & Marketing | 0.00 | 0.00 | 3.62M | 519.92K | 333.44K | 84.32K | 28.32K | 11.90K | 15.65K | 0.00 | 0.00 | 0.00 | 0.00 | 17.18K |
| SG&A | 4.75M | 13.54M | 13.26M | 5.13M | 6.14M | 3.67M | 628.08K | 436.71K | 1.61M | 58.76K | 328.33K | 1.67M | 1.13M | 1.10M |
| Other Expenses | 3.10M | 3.24M | 13.26M | 665.39K | 154.72K | -735.09K | 162.99K | 7.24K | 4.96K | 0.00 | 0.00 | 0.00 | 266.00 | 2.56K |
| Operating Expenses | 7.85M | 16.78M | 13.26M | 5.80M | 6.29M | 3.68M | 791.07K | 443.95K | 1.62M | 58.76K | 328.33K | 1.67M | 1.13M | 1.11M |
| Cost & Expenses | 9.64M | 20.85M | 14.87M | 6.07M | 6.89M | 4.08M | 835.53K | 443.95K | 1.62M | 59.16K | 330.57K | 1.67M | 1.15M | 1.13M |
| Interest Income | 0.00 | 902.13K | 2.10M | 934.68K | 2.52K | 10.33K | 2.84K | 1.17K | 127.00 | 1.00 | 1.00 | 58.00 | 63.00 | 0.00 |
| Interest Expense | 2.51M | 902.13K | 2.10M | 934.68K | 8.79K | 263.51K | 279.22K | 56.23K | 48.67K | 1.00 | 6.28K | 10.74K | 5.54K | 9.72K |
| Depreciation & Amortization | 1.40M | 1.43M | 542.35K | 783.30K | 231.87K | 5.47K | 7.20K | 7.24K | 4.96K | 3.40K | 2.99K | 10.79K | 15.67K | 18.95K |
| EBITDA | -5.82M | -12.59M | -9.52M | -7.16M | -5.66M | -3.84M | -1.85M | -601.58K | -3.54M | -26.24K | -311.22K | -1.65M | -1.13M | -1.09M |
| EBITDA Ratio | -269.84% | -190.57% | -211.14% | -209.46% | -188.67% | -618.46% | -572.52% | -357.77% | -1,464.60% | -71.22% | -1,902.81% | -6,840.67% | -54,586.70% | -4,741.21% |
| Operating Income | -7.49M | -14.17M | -10.27M | -4.36M | -4.58M | -3.42M | -712.79K | -411.55K | -1.83M | -26.59K | -320.50K | -1.66M | -1.15M | -1.12M |
| Operating Income Ratio | -347.28% | -211.92% | -222.99% | -255.28% | -198.83% | -510.88% | -580.70% | -432.55% | -1,778.60% | -81.65% | -1,959.52% | -6,885.46% | -55,612.72% | -4,877.56% |
| Total Other Income/Expenses | -2.24M | -755.24K | -1.90M | -1.34M | -6.27K | -696.50K | -1.43M | -253.50K | -2.02M | 51.00 | 1.00 | 58.00 | 0.00 | 0.00 |
| Income Before Tax | -9.73M | -14.92M | -12.17M | -5.71M | -4.59M | -4.11M | -2.14M | -665.05K | -3.85M | -26.59K | -320.50K | -1.66M | -1.15M | -1.12M |
| Income Before Tax Ratio | -451.25% | -223.22% | -264.31% | -334.17% | -199.11% | -615.06% | -1,743.21% | -698.99% | -3,734.76% | -81.64% | -1,959.51% | -6,883.54% | -55,612.72% | -4,877.56% |
| Income Tax Expense | 9.60K | 793.00 | 1.08K | 3.30K | 2.08K | -432.99K | 279.22K | 56.23K | 48.67K | 1.00 | 6.28K | -58.00 | 5.54K | 9.72K |
| Net Income | -9.74M | -14.92M | -12.17M | -5.72M | -4.59M | -4.11M | -2.14M | -665.05K | -3.85M | -26.59K | -320.50K | -1.66M | -1.15M | -1.12M |
| Net Income Ratio | -451.70% | -223.23% | -264.33% | -334.36% | -199.20% | -615.06% | -1,743.21% | -698.99% | -3,734.76% | -81.64% | -1,959.51% | -6,883.54% | -55,612.72% | -4,877.56% |
| EPS | -0.77 | -4.18 | -9.06 | -24.26 | -33.46 | -43.66 | -58.28 | -20.55 | -80.67 | -0.67 | -8.13 | -42.70 | -32.67 | -9.55K |
| EPS Diluted | -0.77 | -4.18 | -9.06 | -24.26 | -33.46 | -43.66 | -37.57 | -12.73 | -80.67 | -0.67 | -8.13 | -42.70 | -32.67 | -9.55K |
| Weighted Avg Shares Out | 12.59M | 3.57M | 1.34M | 235.65K | 137.25K | 94.19K | 36.71K | 32.37K | 47.71K | 39.57K | 39.43K | 38.85K | 35.19K | 117.00 |
| Weighted Avg Shares Out (Dil) | 12.59M | 3.57M | 1.34M | 235.65K | 137.25K | 94.19K | 56.95K | 52.24K | 47.71K | 39.57K | 39.43K | 38.85K | 35.19K | 117.00 |
Can B Corp. Enters the Industrial Hemp Business
HICKSVILLE, NY / ACCESSWIRE / May 12, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, is pleased to announce its recent purchases of additional equipment in order to increase production at...
Can B Corp. Announces Full Year 2020 Results
Strong Gross Margin of 84% Efficiencies and Lower Expenses Lead to a Significant Reduction in Operating Loss HICKSVILLE, NY / ACCESSWIRE / April 14, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company,...
Can B Corp. to Present at Virtual Investor Summit on March 23, 2021 at 3:00 PM ET
CEO Marco Alfonsi to Highlight the Company's CBD Branded Products and Diverse Sales Channel Strategy HICKSVILLE, NY / ACCESSWIRE / March 22, 2021 / Can B Corp. (OTCQB: CANB) ("Can B" or the "Company"), a diversified health and wellness company,...
Can B Corp. Acquires Assets from Leading-Edge Hemp Technology Group
Adds Expertise in Pharmacokinetics for the Confluence of Science, Nature, and Culture HICKSVILLE, NY / ACCESSWIRE / March 18, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, is pleased to announce...
Can B Corp Partners with Signature PR to Launch a New Premier Line
Targeting Spas, Salons and High-End Retailers
Can B Corp. Accelerates its Innovations and Advancements at Pure Health Products
Expanded Manufacturing Capacity to Lead to Several Additional Revenue Opportunities
Can B Corp and Dr. Karl Zarse Launch ImmuneX2
Targeting Medical Professionals and Direct-to-Consumer Sales Channels to Proactively Optimize Immune Systems
Source: https://incomestatements.info
Category: Stock Reports